Martin Babler
2019
In 2019, Martin Babler earned a total compensation of $5.1M as President and CEO at Principia Biopharma, a 118% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $417,160 |
|---|---|
| Option Awards | $4,094,062 |
| Salary | $556,213 |
| Other | $1,032 |
| Total | $5,068,467 |
Babler received $4.1M in option awards, accounting for 81% of the total pay in 2019.
Babler also received $417.2K in non-equity incentive plan, $556.2K in salary and $1K in other compensation.
Rankings
In 2019, Martin Babler's compensation ranked 2,157th out of 13,971 executives tracked by ExecPay. In other words, Babler earned more than 84.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,157 out of 13,971 | 85th |
Division Manufacturing | 782 out of 5,701 | 86th |
Major group Chemicals And Allied Products | 243 out of 2,200 | 89th |
Industry group Drugs | 196 out of 1,886 | 90th |
Industry Pharmaceutical Preparations | 143 out of 1,398 | 90th |
Source: SEC filing on April 24, 2020.
Babler's colleagues
We found two more compensation records of executives who worked with Martin Babler at Principia Biopharma in 2019.